NS: 25332330
Mobile: 90094424
2:00 – 6:00 pm (weekdays)
Sat. 10:30 AM - 1:30 PM.

News & Articles


NIH-funded tool helps organizations plan COVID-19 testing

Online calculator computes costs of testing and offers strategies for preventing infections in schools and businesses. Read More


High-dose influenza vaccine shows no additional benefit for heart disease patients

NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group. Read More


NIH researchers link cases of ALS and FTD to a mutation associated with Huntington’s disease

Previously unknown genetic connection could be a target for gene therapy. Read More


New updates to federal guidelines revamp asthma management

Updates to six key areas of asthma care focus on improving diagnosis, management and treatment. Read More


NIH Statement on World AIDS Day 2020

We reflect both on the remarkable progress that has been made against HIV as well as the considerable challenges that remain. Read More


NIH announces restructured HIV clinical trials networks

Grant awards set stage for next seven years of science-driven HIV clinical research. Read More


Experimental Vaccine for Deadly Tickborne Virus Effective in Cynomolgus Macaques

Monkeys protected against CCHFV, which infects thousands of people annually Read More


Fourth iteration of COVID-19 treatment trial underway

Study will enroll hospitalized adults with COVID-19 who require supplemental oxygen. Read More


Commonly used antibiotic shows promise for combating Zika infections

NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems. Read More


Decades of NIH research help lead to first FDA-approved treatment for progeria

NIH Director Francis S. Collins, M.D., Ph.D., available to discuss this major advance for rare, fatal pediatric disease. Read More